Keyphrases
Acute Lung Inflammation
100%
PARP Inhibitor (PARPi)
100%
Lipopolysaccharide-induced
100%
Chemokines
20%
Lipid Peroxidation
20%
Neutrophil Accumulation
20%
Lung Inflammation
20%
Pharmacological Inhibitors
20%
Lipopolysaccharide
20%
PJ34
20%
Lung
10%
MIP-2
10%
Interleukin-6
10%
Myeloperoxidase Activity
10%
Nitrate
10%
Malondialdehyde
10%
Pulmonary Inflammation
10%
Interleukin-1β
10%
Permeability Edema
10%
Dual Approach
10%
Cytokine TNF-α
10%
Protein Content
10%
Balb C Mice
10%
Lung Tissue
10%
Histological Analysis
10%
DNA Damage
10%
Lung Damage
10%
Phenanthridinones
10%
Hyperpermeability
10%
Leukocyte Count
10%
Mechanistic Role
10%
Similarity Experiment
10%
High Permeability
10%
NO Production
10%
Nitric Oxide Production
10%
Clinical Conditions
10%
Nitrite
10%
Oxidative Stress
10%
Intratracheal Instillation
10%
Genomic Deletion
10%
Tissue Injury
10%
MIP-1b
10%
Bronchoalveolar Lavage
10%
Pharmacology, Toxicology and Pharmaceutical Science
Lipopolysaccharide-Induced Lung Inflammation
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Lipopolysaccharide
37%
Chemokine
25%
Cytokine
25%
Pneumonia
25%
Tissue Injury
12%
Malonaldehyde
12%
Myeloperoxidase
12%
Interleukin 6
12%
Tumor Necrosis Factor
12%
Oxidizing Agent
12%
Edema
12%
Nitrite
12%
Nitric Oxide
12%
Interleukin 1beta
12%
Protein
12%
Lung Injury
12%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
12%
Bagg Albino Mouse
12%